Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone versus sufentanil combined with ropivacaine for continuous epidural labor analgesia
ChiCTR2000029006Phase 4Recruiting
- Sponsor
- Nanjing Maternal and Child Health Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone, sufentanil and ropivacaine in labor pain (2 arms), sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoint: Consumption of ropivacaine per hour. Started Jan 2020; status: recruiting.
02
Drugs
hydromorphonesufentanilropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2000029006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029006.